
zzso disease continues to be a major cause of death in the Western world and has been extending into areas previously seemingly immune to its zzso zzso interventions and coronary artery bypass surgery have markedly improved cardiovascular health, but a number of patients with coronary artery disease cannot undergo repeated interventions or they receive an incomplete zzso with standard zzso methods, which has been associated with a poor clinical zzso Despite early demonstration of improvement in zzso zzso and function with growth factor, gene therapy or cellular therapies, clinical studies have found little if any real zzso The zzso between positive zzso studies and essentially negative clinical trials may in part be explained by a number of factors including abnormal vascular zzso zzso stress, a hostile local zzso environment and technical issues related to the administration of these zzso Patients with zzso coronary disease are vastly different from the young, healthy animals that are generally used for zzso zzso The presence of diabetes, zzso and other conditions associated with zzso dysfunction and coronary disease and altered vascular signaling can significantly limit the effectiveness of growth factors on the development of collateral zzso This paper summarizes the results of zzso therapies for the treatment of coronary disease and discusses the reasons why growth factor zzso gene therapies and cellular therapies have not been overall successful to zzso 

